Ebsteins anomaly of the tricuspid valve risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by 4 users not shown)
Line 5: Line 5:


==Overview==
==Overview==
* Administration of [[Lithium]] Carbonate or [[benzodiazepines]] during pregnancy is associated with a higher risk of Ebstein's anomaly.
The development of Ebstein's anomaly is associated with the administration of [[Lithium]] Carbonate during the first [[trimester]] or [[benzodiazepines]] during [[pregnancy]].  [[Maternal]] exposure to varnishing substances is also a [[risk factor]] as is a previous history of [[fetal]] loss in the mother.
* Previous history of fetal loss in a mother
 
==Risk factors==
*[[Lithium]] exposure during [[pregnancy]].<ref name="pmid31159903">{{cite journal |vauthors=Downing KF, Riehle-Colarusso T, Gilboa SM, Lin AE, Oster ME, Tinker SC, Farr SL |title=Potential risk factors for Ebstein anomaly, National Birth Defects Prevention Study, 1997-2011 |journal=Cardiol Young |volume=29 |issue=6 |pages=819–827 |date=June 2019 |pmid=31159903 |doi=10.1017/S1047951119000970 |url=}}</ref><ref name="pmid27443814">{{cite journal |vauthors=Hoyt AT, Canfield MA, Romitti PA, Botto LD, Anderka MT, Krikov SV, Tarpey MK, Feldkamp ML |title=Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects |journal=Am. J. Obstet. Gynecol. |volume=215 |issue=5 |pages=613.e1–613.e11 |date=November 2016 |pmid=27443814 |doi=10.1016/j.ajog.2016.07.022 |url=}}</ref><ref name="pmid10697150">{{cite journal |vauthors=Chung KC, Kowalski CP, Kim HM, Buchman SR |title=Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate |journal=Plast. Reconstr. Surg. |volume=105 |issue=2 |pages=485–91 |date=February 2000 |pmid=10697150 |doi=10.1097/00006534-200002000-00001 |url=}}</ref>
*[[Benzodiazepine]] use.
*[[Second-hand smoke|Second-hand]] [[cigarette smoke]] exposure at home.
*[[Family history]] of [[congenital heart defect]](CHD).


==References==
==References==
Line 14: Line 19:
{{WS}}
{{WS}}


[[Category:Disease]]
[[Category:Cardiovascular system]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Congenital heart disease]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Congenital heart disease]]
[[Category:Disease]]

Latest revision as of 20:31, 11 February 2020

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebsteins anomaly of the tricuspid valve risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebsteins anomaly of the tricuspid valve risk factors

CDC on Ebsteins anomaly of the tricuspid valve risk factors

Ebsteins anomaly of the tricuspid valve risk factors in the news

Blogs on Ebsteins anomaly of the tricuspid valve risk factors

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Claudia P. Hochberg, M.D.

Overview

The development of Ebstein's anomaly is associated with the administration of Lithium Carbonate during the first trimester or benzodiazepines during pregnancy. Maternal exposure to varnishing substances is also a risk factor as is a previous history of fetal loss in the mother.

Risk factors

References

  1. Downing KF, Riehle-Colarusso T, Gilboa SM, Lin AE, Oster ME, Tinker SC, Farr SL (June 2019). "Potential risk factors for Ebstein anomaly, National Birth Defects Prevention Study, 1997-2011". Cardiol Young. 29 (6): 819–827. doi:10.1017/S1047951119000970. PMID 31159903.
  2. Hoyt AT, Canfield MA, Romitti PA, Botto LD, Anderka MT, Krikov SV, Tarpey MK, Feldkamp ML (November 2016). "Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects". Am. J. Obstet. Gynecol. 215 (5): 613.e1–613.e11. doi:10.1016/j.ajog.2016.07.022. PMID 27443814.
  3. Chung KC, Kowalski CP, Kim HM, Buchman SR (February 2000). "Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate". Plast. Reconstr. Surg. 105 (2): 485–91. doi:10.1097/00006534-200002000-00001. PMID 10697150.

Template:WH Template:WS